Clinical Drug-Drug Interaction Potential of BFE1224, Prodrug of Antifungal Ravuconazole, Using Two Types of Cocktails in Healthy Subjects-Reference-Cited by-同舟云学术

Clinical Drug-Drug Interaction Potential of BFE1224, Prodrug of Antifungal Ravuconazole, Using Two Types of Cocktails in Healthy Subjects

Published:2018-05-16 Issue:5 Volume:11 Page:477-486
ISSN:1752-8054
Container-title:Clinical and Translational Science
language:en
Short-container-title:Clinical And Translational Science

Author:

Ishii Yasuyuki¹,Ito Yuko¹,Matsuki Shunji²,Sanpei Kasumi³,Ogawa Osamu⁴,Takeda Kenji⁴,Schuck Edgar L.⁵,Uemura Naoto⁶⁷⁸

Affiliation:

1. Shinagawa R&D Center; Sato Pharmaceutical Co.; Tokyo Japan

2. Clinical Research Center; Souseikai Fukuoka Mirai Hospital; Fukuoka Japan

3. Clinical Research Department; Sato Pharmaceutical Co.; Tokyo Japan

4. Research and Development; Seren Pharmaceuticals Inc.; Tokyo Japan

5. Medicines Development Center; Eisai Inc.; Woodcliff Lake New Jersey USA

6. Department of Clinical Pharmacology and Therapeutics; Faculty of Medicine; Oita University; Oita Japan

7. Clinical Pharmacology Center; Oita University Hospital; Oita Japan

8. General Clinical Research Center (GCRC); Oita University Hospital; Oita Japan

Publisher

Wiley

Subject

General Pharmacology, Toxicology and Pharmaceutics,General Biochemistry, Genetics and Molecular Biology,General Medicine,General Neuroscience

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/cts.12557/fullpdf

Reference48 articles.

1. Potential of ravuconazole and its prodrugs as the new oral therapeutics for onychomycosis;Yamaguchi;Med. Mycol. J.,2016

2. Oral antifungal drugs in the treatment of dermatomycosis;Tsunemi;Med. Mycol. J.,2016

3. Multiple cytochrome P-450s involved in the metabolism of terbinafine suggest a limited potential for drug-drug interactions;Vickers;Drug Metab. Dispos.,1999

4. Potent inhibition of cytochrome P-450 2D6-mediated dextromethorphan O-demethylation by terbinafine;Abdel-Rahman;Drug Metab. Dispos.,1999

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lessons learnt from conducting a randomised clinical trial in eumycetoma;The Lancet Infectious Diseases;2024-08

2. Physiologically based pharmacokinetic modeling to predict the clinical effect of azole antifungal agents as CYP3A inhibitors on azelnidipine pharmacokinetics;Drug Metabolism and Pharmacokinetics;2024-04

3. Role of Drug Transporters in Elucidating Inter-Individual Variability in Pediatric Chemotherapy-Related Toxicities and Response;Pharmaceuticals;2022-08-11

4. Eumycetoma causative agents are inhibited in vitro by luliconazole, lanoconazole and ravuconazole;Mycoses;2022-05-06

5. Drug-Drug Interaction Study of Benznidazole and E1224 in Healthy Male Volunteers;Antimicrobial Agents and Chemotherapy;2021-03-18